Business Services Industry

Synchronoss Technologies to Present at 2008 Citi Investment Research Technology Conference

Business Wire, August 26, 2008

BRIDGEWATER, N.J. -- Synchronoss Technologies, Inc. (Nasdaq: SNCR), the premier provider of on-demand transaction management software to Tier One communications service providers, today announced that its Chief Executive Officer and President, Stephen G. Waldis, and Chief Financial Officer and Treasurer, Lawrence R. Irving, will present at the 2008 Citi Investment Research Technology Conference, to be held at the Hilton New York Hotel in New York City, September 2nd through September 4th.

The Synchronoss presentation is scheduled for Thursday, September 4th, 2008, at 11:00 a.m. Eastern Time. A live web cast as well as the replay will be available on the "Investor Relations" page of the company's Web site: www.synchronoss.com.

About Synchronoss Technologies, Inc.

Synchronoss Technologies (NASDAQ: SNCR) is the premier provider of on-demand transaction management software to Tier One communications service providers. Synchronoss enables service providers to drive growth in new and existing markets while delivering an improved customer experience at lower costs. The company's flagship ActivationNow(R) and ConvergenceNow(R) software platforms automate, synchronize and simplify electronic service creation and management of advanced wireline, wireless and IP services across existing networks. For more information, please visit www.synchronoss.com.

The Synchronoss logo, Synchronoss, ActivationNow and ConvergenceNow are trademarks of Synchronoss Technologies, Inc. All other trademarks are property of their respective owners.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale